Ralph A. Tripp - Infectious Diseases

Author Information

Ralph A. Tripp is a distinguished expert in the field of Infectious Diseases, affiliated with the Department of Infectious Diseases at the College of Veterinary Medicine, University of Georgia, Athens, GA, USA. His work primarily focuses on the study of viral pathogens and the development of therapeutic and diagnostic strategies to combat respiratory viruses.

Research Contributions

Ralph A. Tripp has contributed significantly to the understanding and management of respiratory viruses. His recent research includes exploring the structural basis for neutralization of human metapneumovirus, repurposing drugs like Probenecid to inhibit replication of SARS-CoV-2, Influenza Virus, and RSV, and developing rapid detection sensors for coronaviruses. His work also extends to drug repositioning to inhibit viral replication, and the development of antiviral small molecule therapeutics targeting viral surface glycoproteins.

Aliases

Ralph A. Tripp is also known by several aliases including R. A. Tripp, R A Tripp, Ra Tripp, Ralph Tripp, and Ralph A. Tripp.

Publication and Citation Metrics

Metric	Value
Citation Count	18,980
h-index	65
Paper Count	368

Publications:

Structural basis for ultrapotent neutralization of human metapneumovirus

DOI: 10.1101/2022.03.14.484292

Year: 2022

Repurposing Probenecid to Inhibit SARS-CoV-2, Influenza Virus, and Respiratory Syncytial Virus (RSV) Replication

DOI: 10.3390/v14030612

Year: 2022

Probenecid Inhibits Respiratory Syncytial Virus (RSV) Replication

DOI: 10.21203/rs.3.rs-1280404/v1

Year: 2022

Rapid and high-sensitive LSPR sensor for coronavirus detection

DOI: 10.1117/12.2618156

Year: 2022

Silver nanotriangle array based LSPR sensor for rapid coronavirus detection

DOI: 10.1016/j.snb.2022.131604

Year: 2022

Exploring Noncovalent Protease Inhibitors for the Treatment of Severe Acute Respiratory Syndrome and Severe Acute Respiratory Syndrome-Like Coronaviruses

DOI: 10.1021/acsinfecdis.1c00631

Year: 2022

Structure, Immunogenicity, and Conformation-Dependent Receptor Binding of the Postfusion Human Metapneumovirus F Protein

DOI: 10.1128/JVI.00593-21

Year: 2021

Drug repositioning of Clopidogrel or Triamterene to inhibit influenza virus replication in vitro

DOI: 10.1371/journal.pone.0259129

Year: 2021

Intervention Strategies for Seasonal and Emerging Respiratory Viruses with Drugs and Vaccines Targeting Viral Surface Glycoproteins

DOI: 10.3390/v13040625

Year: 2021

From COVID-19 to the Common Cold: Novel Host-Targeted, Pan-Respiratory Antiviral Small Molecule Therapeutics

DOI: 10.1101/2021.01.17.426875

Year: 2021

What are Emerging Viral Threats?

How Does Surveillance Help in Managing Infectious Diseases?

What are T Cells?

How is HIV diagnosed?

What are Natural Killer (NK) Cells?

What is Vaccine Hesitancy?

Why is Biosecurity Important?

What is Efficacy?

What are Antimalarial Drugs?

What are the Treatment Options for Lyme Disease?

Partnered Content Networks

Relevant Topics